Benzinga · Feb 2, 2026
AL
NASDAQ · ALPS
Alps Group Inc
Healthcare · Biotechnology
$0.32
Up+$0.00 (+0.00%)
Updated Nov 5, 2026, 7:11 AM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 159.74M
- P/E ratio
- -1.24
- Dividend yield
- 0.00%
- 52-week range
- $0.23 – $1.39
- Volume
- 78.75K
- Avg. volume
- 57.92K
Price performance · ALPS
ALPS price history
1M range · 0 trading sessions · Daily adjusted prices
ALPS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ALPS news
The latest Smart Investors Daily articles mentioning ALPS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ALPS research
Overview
Company profile and research snapshot.
Company profile
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
globenewswire.com · Oct 31, 2025
Alps Announces Closing of Business Combination with Globalink Investment Inc.
Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025 Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
